Superficial corneal dystrophy is a rare, inherited disorder that affects the cornea, the clear, dome-shaped surface of the eye. This condition is characterized by the accumulation of abnormal deposits or opacities in the outer layers of the cornea, which can affect a person’s vision. As the name suggests, the deposits form in the superficial layers of the cornea, typically not affecting the deeper layers of the eye. While superficial corneal dystrophy is generally not life-threatening, it can lead to significant visual impairment over time, particularly if left untreated.
The underlying cause of superficial corneal dystrophy is often genetic, and it is inherited in an autosomal dominant pattern, meaning that only one copy of the defective gene from either parent is needed for the condition to be passed down. This type of dystrophy typically manifests in childhood or early adulthood, although the severity of symptoms can vary widely among individuals. In some cases, the disease may remain relatively stable throughout life, while in others, it can progress and cause more noticeable visual disturbances.
There are several different types of superficial corneal dystrophies, each with its own specific characteristics and patterns of progression. The most common form of superficial corneal dystrophy is Epithelial Basement Membrane Dystrophy (EBMD), which involves the formation of abnormal cell layers within the epithelium, the outermost layer of the cornea. EBMD is often associated with symptoms like blurred vision, glare, and recurrent corneal erosions—episodes in which the outer layer of the cornea becomes detached, leading to pain, discomfort, and temporary vision loss.
Another form of superficial corneal dystrophy is Meesmann’s dystrophy, which is characterized by the development of small, cyst-like structures in the corneal epithelium. These cysts can cause irritation and may lead to progressive vision problems as the disease advances. Although distrofia corneale superficiale both EBMD and Meesmann’s dystrophy are considered forms of superficial corneal dystrophy, they differ in their specific symptoms and genetic causes.
The symptoms of superficial corneal dystrophy often arise due to the accumulation of abnormal deposits or changes in the structure of the cornea. As these deposits scatter light entering the eye, it can cause a range of visual disturbances, such as blurred vision, difficulty seeing at night, and increased sensitivity to light. Some individuals may also experience eye irritation, excessive tearing, or a sensation of a foreign body in the eye. In more severe cases, the recurrent erosions can cause scarring on the surface of the cornea, further compromising vision.
Diagnosing superficial corneal dystrophy typically involves a thorough eye examination using slit-lamp imaging. A slit lamp allows the eye doctor to closely examine the cornea and look for signs of abnormal deposits or structural changes. In some cases, additional testing, such as corneal topography or genetic testing, may be conducted to confirm the diagnosis and assess the specific type of dystrophy.
While there is no cure for superficial corneal dystrophy, several treatment options are available to manage the condition and alleviate symptoms. For mild cases, lubricating eye drops or ointments may help relieve dryness and irritation, improving comfort and reducing the risk of erosions. In more severe cases, patients may benefit from phototherapeutic keratectomy (PTK), a laser procedure used to remove the abnormal cells or deposits on the corneal surface. PTK can help improve vision and reduce discomfort caused by recurrent erosions.
For individuals with recurrent corneal erosions, hypertonic saline drops or ointments may be used to help reduce swelling and promote healing of the corneal surface. In some cases, a procedure called Anterior Lamellar Keratoplasty (ALK) may be recommended, which involves replacing the superficial layers of the cornea with healthy tissue to restore vision and improve eye health.
Genetic counseling can also be helpful for individuals with a family history of superficial corneal dystrophy. Understanding the hereditary nature of the condition can assist family members in making informed decisions about genetic testing and monitoring their eye health.
In conclusion, superficial corneal dystrophy is an inherited condition that affects the outer layers of the cornea, leading to visual disturbances and potential discomfort. While there is no cure for the condition, various treatment options are available to manage symptoms and improve the quality of life for affected individuals. With early diagnosis, appropriate management, and ongoing monitoring, people with superficial corneal dystrophy can maintain good eye health and enjoy a relatively normal lifestyle.
About the author